| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |